Wire flash
Xinhua Winshare Plans to Acquire Publisher from Controlling Shareholder for 346M Yuan, Media Sector Rises
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
On September 24, China's A-share markets opened lower with most sectors declining. However, the media sector rallied, led by Xinhua Winshare Publishing (stock code 601811) which hit its fifth consecutive daily limit-up. The move was attributed to the company's announcement of a 346 million yuan acquisition of its parent's publishing assets. Separately, AI-driven pharmaceutical (AI Pharma) stocks rose following the release of the '15th Five-Year Plan' for the pharmaceutical industry by ten government departments, which explicitly calls for accelerating AI-driven drug R&D and production management transformation. The article also notes strength in Tesla robot-related stocks after a forecast by Tesla that humanoid robot demand could reach 10 billion units in 15 years and 100 billion in 20 years. Other sectors mentioned include coal, VNA instruments, and real estate. The article is a compilation of market movements and related news snippets sourced from Securities Times.
Source report
Major A-share indices opened lower on September 24, with most sectors declining in early trading.
Sector Performance
Declining sectors included photoresist, precious metals, semiconductors, and real estate services.
Media sector showed activity, with stocks such as Xinhua Winshare, Xinhua Media, Topvision Video, Yue Media, and Inner Mongolia Xinhua moving higher.
News driver: Xinhua Winshare recently announced plans to acquire 100% equity of Sichuan Xinhua Publishing House Co., Ltd. from its controlling shareholder for RMB 346 million. The transaction is classified as a related-party deal and does not constitute a major asset restructuring.
AI pharmaceuticals saw an unusual rally, with stocks including Berry Genomics, BGI Genomics, Rongtai Health, Selis Medical, Yiqiao Shenzhou, and Kingmed Diagnostics gaining.
Policy backdrop: The Ministry of Industry and Information Technology, along with nine other government departments, recently released the "15th Five-Year Plan for Pharmaceutical Industry Development," which explicitly calls for accelerating AI-driven transformation in pharmaceutical R&D and production management. Additionally, recent moves by multinational and domestic pharmaceutical companies in AI drug development have drawn increased capital market attention.
Coal sector stocks including Yunnan Coal Energy, Zhengzhou Coal, Liaoning Energy, Antai Group, and Shaanxi Black Cat were in focus, following data from SunSirs on September 24 regarding thermal coal prices.
VNA instrument concept strengthened, with stocks such as Oriental Zhongke, Ceyuan Instrument, Chuangyuan Xinke, Tonghui Electronics, and Weixing Intelligent gaining.
Robotics sector saw movement in stocks including Xiangyang Bearing, Ningbo Dongli, Wanxiang Qianchao, Nanfang Precision, Sanhua Intelligent, and Tuopu Group.
News driver: On September 23, Tesla indicated that there could be at least 1 billion humanoid robots, potentially reaching 10 billion within 15 years and 100 billion within 20 years.
Real estate sector included stocks such as Huali Family, Huayuan Holdings, Greenland Holdings, Xiangjiang Holdings, Vanke A, and Rongsheng Development.
Other mentions: Huatai Securities, data center PCB.
Source: Securities Times
Source
东方财富网-A股公司Eastern
Part of this Story
China A-Share Markets Rally on AI Drug Policy, Tech Gains, and Tesla Robot Supply Chain News